|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cervical Cancer Screening Coverage — China, 2018–2019显示文摘What is already known about this topic?The World Health Organization set a 2030 target of 70%cervical cancer screening coverage for women aged 35–45 years.Coverage stood at 37%in China in 2015.What is added by this report?In 2018–2019,China’s cervical cancer screening coverage reached 43.4%in women aged 35–44 years and 36.8%in women aged 35–64 years.Screening coverage was still lower in rural areas as well as central and western regions;large variations existed across provincial-level administrative divisions.What are the implications for public health practice?National and local policy and financial support should be maintained for cervical cancer screening,along with more targeted health education and outreach efforts and strengthened accessibility of health services in the rural areas and central and western regions. | Mei Zhang Yijing Zhong Limin Wang Heling Bao Zhengjing Huang Zhenping Zhao Xiao Zhang Chun Li Kelly Liang Sun Jing Wu Xiaoying Zheng Linhong Wang | 2022 | China CDC weekly2022，4，48： | 11 |
| 2 | Breast Cancer Screening Rates Among Women Aged 20 Years and Above—China,2015显示文摘What is already known about this topic?Breast cancer is the most common cancer in women in China and around the world.By 2019,121 countries have instituted a national screening program as a secondary prevention measure for breast cancer.What is added by this report?Breast cancer screening rates in China were 18.9%in women aged 20 years and above,and 25.7%in women aged 35-64 years in 2015.The screening rate for women aged 20 years and above was significantly higher in urban areas than in rural areas(24.6%vs.15.0%),and in the eastern region than in the central and western regions(24.0%vs.15.1%and 15.3%). | Mei Zhang Yijing Zhong Heling Bao Zhenping Zhao Zhengjing Huang Xiao Zhang Chun Li Maigeng Zhou Limin Wang Jing Wu Xiaoying Zheng Linhong Wang | 2021 | China CDC weekly2021，3，13： | 5 |
| 3 | Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era—China,2017–2018显示文摘What is already known about this topic?Human papillomavirus(HPV)type-specific strategies play a key role in the prevention of cervical intraepithelial neoplasia(CIN),but evidence on the HPV type-specific prevalence in CIN is limited.What is added by this report?This multicentric study estimates the prevalence of high-risk HPV types in CIN cases and the associations of HPV infection patterns with high-grade CIN in China in 2017–2018.What are the implications for public health practice?Population-based prevention strategies should give preference to HPV-16 and 18,and strategies for non-16/18 high-risk HPV are essential for the elimination of cervical cancer. | Heling Bao Weihong Chen Xiaosong Zhang Hui Bi Yun Zhao Liwen Fang Shu Cong Feng Tan Linhong Wang | 2022 | China CDC weekly2022，4，48： | 1 |
| 4 | Age-specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross-sectional study显示文摘Background:Primary human papillomavirus(HPV)screening is recommended for the detection of cervical intraepithelial neoplasia(CIN)in the general pop-ulation;however,the triage for HPV-positive women remains a challenge.This study aimed to evaluate the age-specific effectiveness of primary HPV screening versus primary cytology screening for identifying optimal strategies for women of different ages.Methods:The dataset of the prevalence round screening was derived from the National Cervical Cancer Screening Program in China.Primary cervical screen-ing protocols included cytology only,HPV testing with cytology triage,and HPV testing with HPV-16/18 genotyping plus cytology triage.The primary outcomes were age-specific detection rate,colposcopy referral rate and positive predictive value(PPV)for CIN2+.Multivariate Poisson regression was used to evaluate the relativeeffectivenessofHPVtestingandcytologyaccordingtoagegroups.TheI 2 statisticwitharandom-effectmodelwasusedtotesttheheterogeneityinrelative effectiveness of HPV testing versus cytology between age groups.Results:This study included 1,160,981 women.HPV testing with HPV-16/18 genotyping plus cytology triage significantly increased the CIN2+detection by 36%(rate ratio[RR]:1.36,95%confidential interval[CI]1.21–1.54)for women aged 35-44 years and by 34%(RR:1.34,95%CI 1.20-1.51)for women aged 45-54 years compared with cytology only.HPV testing with cytology triage had simi-lar CIN2+detection rate compared with cytology only.The PPVs were substan-tially increased for both HPV testing groups.Among women aged 55-64 years old,HPV testing with HPV-16/18 genotyping plus cytology triage increased the colposcopyreferralrateby19%(RR1.19,95%CI1.10-1.29)comparedwithcytology only,butdidnotincreasetheCIN2+detection(1.09,0.91–1.30).Theeffectiveness ofHPVtestingwithcytologytriagedidnotchangeinolderwomen.Thebetween-age-group heterogeneity in the effectiveness was statistically significant for HPV testing with HPV-16/18 genotyping plus cytology triage versus cytology only.Conclusions:Our results suggested that the effectiveness of primary HPV screeningwithdifferenttriagestrategiesdifferedamongagegroups.HPVtesting with HPV-16/18 genotyping plus cytology triage could be used for women aged 35-54 years to detect more lesions,and HPV testing with cytology triage could balance the CIN2+detection and the number of colposcopies for women aged 55-64 years.Longitudinal data including both prevalence and incidence screen-ing rounds are warranted to assess age-specific triage strategies. | Heling Bao Lan Ma Yanxia Zhao Bo Song Jiangli Di Linhong Wang Yanqiu Gao Wenhui Ren Shi Wang Jiuling Wu Hai-Jun Wang | 2022 | Cancer Communications2022，42，3： | 1 |
| 5 | Breast Cancer Screening Coverage—China,2018-2019显示文摘Summary What is already known about this topic?In 2015,only 18.9%of adult women underwent breast cancer screening in China.What is added by this report?Breast cancer screening coverage for women aged 20 years and above in China reached 22.3%during 2018-2019.Women with lower socioeconomic status had lower screening coverage.There were significant variations across the provincial-level administrative divisions. | Mei Zhang Heling Bao Xiao Zhang Zhengjing Huang Zhenping Zhao Chun Li Maigeng Zhou Jing Wu Limin Wang Linhong Wang | 2023 | China CDC weekly2023，5，15： | 0 |
| 6 | Breast Cancer Awareness and Association with Frequency of Screening Among Women—China,2020显示文摘Summary What is already known about this topic?Breast cancer awareness plays a crucial role in promoting screening attendance,enabling early detection,and improving survival rates associated with breast cancer.Nevertheless,a persistent issue is the low public awareness of breast cancer warning signs and risk factors. | Heling Bao Liyuan Liu Shu Cong Fei Wang Lixiang Yu Liwen Fang Xuening Duan Feng Tan Zhigang Yu Linhong Wang | 2023 | China CDC weekly2023，5，15： | 0 |
| 7 | Depressive Symptoms and Sleep Duration as Risk Factors for Breast Cancer—China,2020显示文摘Summary What is already known about this topic?Psychological and lifestyle factors are known to potentially play a significant role in the development of breast cancer.However,current evidence-based studies present controversial findings on the associations between depression,sleep duration,and breast cancer risk. | Liyuan Liu Heling Bao Fei Wang Lixiang Yu Shu Cong Fei Zhou Yujuan Xiang Shuya Huang Chao Zheng Liwen Fang Linhong Wang Zhigang Yu | 2023 | China CDC weekly2023，5，15： | 0 |
| 8 | Using Healthcare Big Data Analytics to Improve Women’s Health:Benefits,Challenges,and Perspectives显示文摘Women’s health is of paramount importance for the attainment of the Sustainable Development Goals(SDGs)and Healthy China 2030,encompassing reproductive health and physical and mental well-being.This multifaceted concept of health is integral to the health of maternal,newborn,child,adolescent,and adult populations(1-3). | Heling Bao Hui Liu Linhong Wang | 2024 | China CDC weekly2024，6，10： | 0 |
| 9 | Variations in the Prevalence of Anemia of Varying Severity Among Urban Non-Pregnant Women—China,2021显示文摘Summary What is already known about this topic?Anemia is a significant public health issue affecting women globally.Prior studies in China predominantly concentrated on anemia in pregnant or reproductiveage women,leaving a gap in available data concerning anemia in non-pregnant women of all age groups in China. | Xiaoxi Liu Bo Wang Sailimai Man Heling Bao Yuanyuan Huang Canqing Yu Jun Lyu Linhong Wang Liming Li Hui Liu | 2024 | China CDC weekly2024，6，10： | 0 |
| 10 | Distribution of Chronic Obstructive Pulmonary Disease--China,2014−2015显示文摘Introduction:Chronic obstructive pulmonary disease(COPD)has become a major public health problem in China.However,prevalence of COPD by demographics in different regions has not been estimated.This analysis aims to compare the prevalence of COPD by age and sex and the prevalence of disease severity by Global Initiative for Chronic Obstructive Lung Disease(GOLD)stages in the East,Central,and West of China.Methods:Data from a nationwide surveillance in China between 2014 and 2015 were used,which recruited 66,752 adults aged 40 years or over.All participants underwent pre-and post-bronchodilator pulmonary function tests.COPD and the severity of disease were defined based on the 2018 GOLD lung function criteria.Results:The prevalence of COPD was 13.7%,10.9%,and 16.9%in the East,Central,and West,respectively.In all age and gender groups,the prevalence was highest in the West,followed by the East,with the lowest prevalence in Central.The prevalence of mild disease(GOLD stage I),moderate disease(GOLD stage II),severe disease(GOLD stage III),and very severe disease(GOLD stage IV)was also the highest in the West.The prevalence of COPD in each region increased significantly with age and was consistently higher in men than in women.Conclusions and Implications for Public Health Practice:With the support of Healthy China 2030,the government should widely publicize the risk factors and early symptoms of COPD to promote the prevention on COPD and the awareness of early detection among population.The capacity of diagnosis and treatment of COPD among primary healthcare institutions and healthcare workers should be strengthened,particularly in the West,where the prevalence of COPD is comparatively high and health resources are relatively scarce. | Ning Wang Shu Cong Jing Fan Heling Bao Baohua Wang Linhong Wang Liwen Fang | 2020 | China CDC weekly2020，2，15： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员